Innovative Bayesian statistics for enhanced decision making for pharmaceutical drug development

该项目解决了澳大利亚促进和维持良好健康的国家研究重点，并将通过患者更快地获得新药、加强研究并降低医疗保健成本来改善健康结果。将通过使用新的统计方法改进药物开发早期阶段的决策，这种方法也可以应用于涉及决策程序的各种情况。这将通过跨学科和大学与行业的合作实现，利用澳大利亚和国际的专业知识。国家对作为卫生决策基础的高质量科学和训练有素的研究人员的需求将得到促进。

This project addresses Australia's national research priority of Promoting and Maintaining Good Health, and will lead to improvements in health outcomes by patients accessing new drugs sooner, enhancing research, and reducing the cost of health care. Decision making in early stages of drug development will be improved by using novel statistical methods, which could also be applied in a variety of situations involving decision making procedures. This will be achieved through cross-disciplinary and university-industry collaboration, utilising Australian and international expertise. National demands for quality science and trained researchers underpinning health decisions will be contributed to.